SVSara Vogrin

Sara Vogrin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Sara Vogrin has a total of 618 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Burden of Keratinocyte Cancers in Renal Transplant Recipients: A Retrospective Cohort Study

    by Blake P. Mumford, Sara Vogrin, Laxmi Iyengar, Jane Li, Michelle S. Y. Goh, Sarah Brennand, David Goodman, Alvin H. Chong

    Objectives: Renal transplant recipients (RTRs) are at increased risk of keratinocyte cancer (KC) development due to immunosuppression. A single‐centre retrospective cohort study was conducted to determine the incidence, risk factors and impact on mortality of KCs in RTRs. Methods: All RTRs attending an adult transplant dermatology service in Victoria, Australia between 1 January 2004 and 1 March 2020 were included. Age, gender, age at transplantation and immunosuppression regimen were recorded at baseline. At each encounter, a whole body examination was performed, and histologically confirmed KCs were recorded. Linkage was performed with the Australia and New Zealand Dialysis and Transplant Registry to obtain mortality data. Results: Of the 414 participants, 162 (39%) were diagnosed with a KC (basal cell carcinoma [BCC], invasive squamous cell carcinoma [SCC], or squamous cell carcinoma in situ [SCCis]). A total of 1110 KCs were diagnosed. Of these, 451 (40.63%) were invasive SCC, 341 (30.72%) were BCC and 318 (28.65%) were SCCis. Risk factors for KC included skin phototype 1 or 2, exposure to mycophenolate (aHR 2.19, CI 1.39–3.46, p = 0.001), male gender (aHR 1.84, CI 1.27–2.68, p = 0.01), older age (aHR 1.28, CI 1.19–1.38, p < 0.001) and longer transplant duration (aHR 1.15, CI 1.04–1.28, p = 0.005). Eighty‐two (19.8%) patients died, most commonly of malignancy ( n = 21, 25.6%). Diagnosis of invasive SCC was associated with mortality in univariate analysis (HR 2.85; 95% CI, 1.82–4.46 p < 0.001) but narrowly failed to reach significance on multivariable analysis (HR 1.59, CI 0.92–2.76, p = 0.098). Conclusions: These findings highlight the burden of KC‐related morbidity and mortality in RTRs. Vigilant monitoring is of vital importance in this population.

  • Medial joint opening on immediate postoperative supine radiographs predicts inferior midterm functional outcomes in women after total knee arthroplasty

    by Eran Keltz, Eugenie Ng, Libby Spiers, Oren Tirosh, Saud Almaslmani, Sara Vorgin, Phong Tran

    Routine postoperative radiographs are common after total knee arthroplasty (TKA), yet their value for assessing early joint balance is unclear. Immediate supine, non-weight-bearing anteroposterior radiographs may show coronal gap asymmetry, but its long-term significance remains uncertain. This study evaluated whether medial–lateral joint space differences on day-one radiographs correlate with midterm patient-reported outcomes. A retrospective cohort of 637 mechanically aligned primary TKAs (556 patients, 2012–2017) was analysed. Medial and lateral gaps were digitally measured on immediate postoperative supine AP and lateral radiographs. Gap asymmetry was expressed as an absolute difference and as a medial-to-lateral ratio. Patient-reported outcome measures (PROMs)—Oxford Knee Score (OKS), pain VAS, and EQ-5D VAS—were assessed at ≥ 3 years. Multivariable linear and logistic regression adjusted for age, sex, and BMI examined associations between radiographic imbalance and outcomes. Median follow-up was 5.4 years. The median lateral–medial gap difference improved from 4.9 mm preoperatively to 0 mm postoperatively. In women < 70 years, each 1-mm medial opening was associated with a 1-point lower OKS and 2.4-point lower EQ-5D VAS. A 100% increase in the medial–lateral ratio predicted an 8.8-point lower OKS in women < 60 years and a 4-point lower OKS in women 60–70 years. Medial opening ≥ 1.5 mm predicted poorer OKS and EQ-5D scores, whereas mild lateral opening showed outcomes comparable to symmetric knees. No significant associations were found in men. Medial joint space widening ≥ 1.5 mm or ≥ 100% ratio increase on day-one radiographs predicts poorer midterm outcomes in women < 70 years, suggesting that early coronal imbalance has lasting clinical relevance in this group.

  • Open Access

    Implementing a Same-Day PCI Protocol in Australia: Impact on Uptake, Safety, and Quality of Life

    by Jack L. Bradbury, Sara Vogrin, Jason Nogic, Ali Al-Fiadh, David J. Clark, Dharsh Fernando, Omar Farouque, Garry Hamilton, Rafi Huq, Anoop N. Koshy, et al.

  • Open Access

    Pilot randomised controlled trial of probe to bone diabetic foot ulcer therapy (PROBE-DFU trial) – Study protocol

    by Satwik Motaganahalli, Sara Vogrin, Toby Richards, Trisha Peel, Jason Trubiano

    Background: The probe-to-bone (PTB) is a simple, bedside clinical test that can assist in diagnosis of diabetic foot osteomyelitis (OM). The utility of PTB varies depending on the population, with a lower positive predictive value in lower-risk outpatients. Methods: This is a protocol for a pilot, feasibility and safety multi-centre randomized controlled trial. 80 patients, with PTB diabetic foot ulcers and without initial X-ray findings of OM, will be randomized to 2 weeks antibiotic therapy or 6 weeks of antibiotic therapy at a 1:1 ratio. The primary outcomes will be to assess feasibility (eligibility to recruitment ratio, retention rate, adherence to protocol and cross-over from intervention to control group) and safety (serious adverse events, antibiotic-associated adverse events, Clostridium difficile associated diarrhea and hospitalization) in this cohort. Exploratory clinical outcomes will include recommencement/continuation of antibiotic therapy or requirement for surgery, and the proportion of participants that demonstrate new radiological changes of OM on serial X-ray imaging. Follow-up will occur at 14 days, 42 days and 90 days post-recruitment. Discussion: This is the first randomised trial assessing the feasibility and safety of shorter antibiotic therapies in patients with low-risk PTB diabetic foot ulcers. The findings of this trial will inform the design of future large multi-site randomised trials to risk stratify diabetic foot ulcers and better understand how to treat diabetic foot OM. Trial Registration: Australian New Zealand Clinical Trials Registry (ANZCTR): 12624000266561. Registered on 15/03/2024.Registration URL: https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=386823&isReview=true

  • Open Access

    The SINFONIA Study: A Randomised Controlled Trial to Determine Feasibility and Effectiveness of Online Group Singing for People With COPD or ILD and Breathlessness

    by Natasha Smallwood, Amy Pascoe, Nicole Goh, Stefanie Zappino, Sara Vogrin, Lena Ly, Catherine Buchan, Anna Spathis, Jennifer Philip

    Background and Objective: People with chronic obstructive pulmonary disease ( COPD ) and interstitial lung disease ( ILD ) experience chronic breathlessness and reduced quality of life ( QOL ). Specialised singing programs for people with lung disease may improve QOL and symptoms. Methods: A randomised controlled trial conducted in Australia to determine the feasibility and effectiveness of 12 weeks of online, guided group singing on QOL (primary outcome, as measured by SF36), as compared to usual care in people with COPD or ILD. Secondary outcomes: anxiety, depression, dyspnoea and loneliness. Intervention effectiveness was assessed using mixed effects linear regression. Results: One hundred and one participants were randomised (50 singing, 51 control; 64 COPD, 37 ILD; mean age 69.6 years; 74% women; 42% mMRC = 2, 58% mMRC ≥ 3). The results of the primary endpoint were a mean treatment effect (MTE) of singing of 2.5 points (95% CI −1.9 to 6.8; p = 0.266) on SF‐36 mental health score (MCS) and 2.6 points (95% CI −0.9 to 6.1; p = 0.138) on the physical component score (PCS), neither of which were statistically or clinically significant. In the per‐protocol analysis, significant improvement in MCS was detected in participants who attended 8 or more sessions (MTE:4.8; 95% CI 0.1 to 9.5; p = 0.047). No significant effects on secondary outcomes were detected. No adverse events were reported. Conclusions: This RCT demonstrated that online group singing is a feasible intervention for people with COPD or ILD and breathlessness. Although the intention‐to‐treat analysis did not demonstrate effectiveness, per‐protocol analyses suggest that singing may improve mental health components of QOL in people with COPD or ILD.


  • Open Access

    Antifungal resistance mechanisms and nosocomial transmission of Nakaseomyces glabratus: genomic investigation and observational study in Melbourne, Australia

    by Andrew Gador-Whyte, Torsten Seemann, Louise M Judd, Kristy A Horan, Jake A. Lacey, Ana Traven, Diane Daniel, Romain Guérillot, Stefano Giulieri, Sara Vogrin, et al.

    Nakaseomyces glabratus (Candida glabrata) is a WHO high-priority fungal pathogen associated with fungal antimicrobial resistance (fAMR). Given nosocomial transmission occurs sporadically, resistant strains could be transmitted, a concern for critically ill patients. We conducted a genomic investigation and retrospective observational study of N. glabratus to identify any nosocomial transmission of fAMR and understand resistance mechanisms and clinical and demiological factors among patients at a quaternary hospital in Melbourne, Australia. We selected stored N. glabratus with and without fAMR associated with similar patient clinical characteristics and performed whole genome sequencing. Clinical and epidemiological data were extracted from medical records. Phylogenetic, mutational, copy-number variation (CNV) and mitochondrial genomic analyses were performed, with a focus on the fAMR gene PDR1. Of 54 isolates collected over seven years, 20 (37%) were fluconazole-resistant and four (7%) had elevated flucytosine minimum inhibitory concentrations (MICs) (range 2-32 μg/ml). There were no significant clinical differences between patients with and without fluconazole resistance. Most (55%) fluconazole-resistant isolates carried PDR1 mutations. Resistance was distributed throughout the phylogeny suggesting predominantly independent acquisition. However, a cluster of four resistant isolates with the same PDR1 mutation suggested nosocomial transmission. One probable ERG11 gene duplication, and two petite variants with apparent mitochondrial genomic deletions, were seen in association with fluconazole resistance. In this study, we identified a small probable nosocomial fAMR transmission cluster, and novel variants in PDR1, ERG11 and FCY2 associated with fAMR phenotypes. Future study should confirm functional impacts and systematically investigate for nosocomial transmission of resistance, including colonisation states.

  • Low Risk Is Low Risk: iNAAN Post Hoc Analysis of Phenotypic Predictors of Penicillin Direct Oral Challenge Safety

    by Elise A. Mitri, Sara Vogrin, Jonny G. Peter, Philip H. Li, Ana-Maria Copaescu, Cascia Day, Michelle Goh, Ami P. Belmont, Suran L. Fernando, Jason A. Trubiano, et al.


  • Open Access

    Two decades of biologic and JAK inhibitor prescription patterns in the western region of Melbourne

    by Alexander Kwan, Elvina Ingrid, Sara Vogrin, Ken Luong, Fei Jin, Emma Brown, Dongzhe Li, Matthew Jiang, Keith K. T. Lim

    Background and Aim: Safety concerns and medication shortages may influence prescribing practices in rheumatology. This study aimed to explore the impact of Janus kinase inhibitor (JAKi) safety warnings and the COVID‐19 pandemic on biologic and targeted‐synthetic disease‐modifying antirheumatic drug (b/tsDMARD) prescription patterns from 2002 to 2024 in the western region of Melbourne. Methods: A retrospective audit was conducted on data from rheumatoid arthritis (RA), psoriatic arthritis (PsA) and ankylosing spondylitis (AS) patients who attended Western Health and Western Rheumatology clinics between 2002 and January 2024 inclusive. b/tsDMARD switching was analysed based on the first date of b/tsDMARD prescription using interrupted time series analysis, with ethics approval granted by the Western Health Office for Research (HREC/23/WH/101783). Results: There were 3124 new b/tsDMARD prescriptions. Following the 2021 United States JAKi boxed warning, the JAKi prescription rate decreased to −0.04/month (−0.20, 0.11) from 0.30/month (0.18, 0.42), P = 0.002. Supply shortages during the COVID‐19 pandemic led to 44 b/tsDMARD switches. The most common cause of switching was inefficacy (32.6% of new prescriptions for AS, 42.6% for RA and 46.1% for PsA ( P < 0.001)). Less than 5.4% of new prescriptions were from adverse events, underscoring b/tsDMARD safety. Conclusions: b/tsDMARD switches were primarily driven by inefficacy. Black box warning issuance led to decreased JAKi prescriptions. The COVID‐19 pandemic led to minimal b/tsDMARD switches. Switching due to adverse events was infrequent, highlighting the overall safety of b/tsDMARDs in clinical practice.

  • Complex Problem, Digital Cure? Rethinking Penicillin Allergy Relabeling Using Technology-Enabled Care

    by Elise A Mitri, Sara Vogrin, Gemma K Reynolds, Ana Maria Copaescu, Fionnuala Cox, Jamie L Waldron, Jonny G Peter, Jason A Trubiano, International Network of Antibiotic Allergy Nations (iNAAN) study group